The Effect of Combined Spinal Epidural Anaesthesia on QTc Interval Undergoing Cesarean Section
1 other identifier
interventional
50
1 country
1
Brief Summary
Cesarean section is the operation to deliver the fetus, placenta and membranes by making an abdominal incision in the uterus. Cesarean section is performed for reasons such as head-pelvis incompatibility, fetal malposition, fetal distress, and previous cesarean section. The most important side effects of spinal anaesthesia are problems such as hypotension, bradycardia, low back pain, headache, nausea, vomiting, meningitis, meningismus, and urinary retention. Combined spinal-epidural (BSI) anaesthesia is the application of spinal and epidural anaesthesia together. High-dose local anaesthetics can cause significant hypotension when the epidural block is administered alone. The administration of spinal anaesthesia alone causes changes in arterial resistance, stroke volume, heart rate, cardiac output and arterial blood pressure. Sympathetic blockade leads to arterial vasodilation, and arterial resistance may decrease by 5-20% during spinal anaesthesia. Due to the increased risk of maternal complications in obese pregnant, fetal morbidity and mortality have increased. In addition, supine hypotension syndrome is a common problem in obese pregnant women. The aim of this study is to compare the change in QTc interval in obese and non-obese term pregnancies planned for elective cesarean section with combined spinal epidural anaesthesia. Thus, it is aimed to develop new protocols that will minimize cardiac pathologies during and after surgery in obese pregnant women.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 24, 2023
CompletedStudy Start
First participant enrolled
July 24, 2023
CompletedFirst Posted
Study publicly available on registry
August 31, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedFebruary 6, 2024
February 1, 2024
1.4 years
July 24, 2023
February 5, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
QTc interval
The primary aim of this study was to reveal the difference in QTc interval between groups.
first 2 hour starting from the time of CSE performed.
Study Arms (2)
Body Mass Index≥30 kg/m2
ACTIVE COMPARATORPregnant women with a Body Mass Index≥30 kg/m2 will be included.
Body Mass Index: 18,5 - 24,9 kg/m2
ACTIVE COMPARATORPregnant women with a Body Mass Index between 18.5 and 24.9 kg/m2 will be included.
Interventions
Combined epidural spinal anesthesia will be performed with the loss of resistance method at constant volume and concentration ( in both patient groups. For QT interval measurements, ECG recordings will be taken before spinal anesthesia, 5 and 30 minutes after the block, and 60 and 120 minutes postoperatively.
Combined epidural spinal anesthesia will be performed with the loss of resistance method at constant volume and concentration in both patient groups. For QT interval measurements, ECG recordings will be taken before spinal anesthesia, 5 and 30 minutes after the block, and 60 and 120 minutes postoperatively.
Eligibility Criteria
You may qualify if:
- Participants with BMI≥30 and BMI values between 18.5 and 24.9.
You may not qualify if:
- allergic to the drugs used in the study,
- who do not accept regional anesthesia,
- under 150 cm in height,
- who received treatment other than perinatal iron and vitamin drugs,
- smoking or drinking alcohol,
- with a known fetal anomaly,
- with placental disorders such as placenta previa,
- with multiple pregnancy
- have renal or liver disease,
- diagnosed with hypertension or preeclampsia,
- uncooperative and previously treated or currently receiving treatment for a psychiatric disorder
- Mothers who do not want to participate in the study will not be included in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ataturk University
Erzurum, 25100, Turkey (Türkiye)
Related Publications (2)
Kumar T, Jha K, Sharan A, Sakshi P, Kumar S, Kumari A. Study of the effect of obesity on QT-interval among adults. J Family Med Prim Care. 2019 May;8(5):1626-1629. doi: 10.4103/jfmpc.jfmpc_168_19.
PMID: 31198727BACKGROUNDSong JH, Yang C, Lee W, Kim H, Kim Y, Kim H. QTc interval prolongation due to spinal anesthesia in patients with and without diabetes: an observational study. BMC Anesthesiol. 2022 May 13;22(1):143. doi: 10.1186/s12871-022-01614-8.
PMID: 35562669BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Mehmet Aksoy
Ataturk University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 24, 2023
First Posted
August 31, 2023
Study Start
July 24, 2023
Primary Completion
November 30, 2024
Study Completion
December 31, 2024
Last Updated
February 6, 2024
Record last verified: 2024-02